Cargando…
Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole
BACKGROUND: The pharmacokinetics and pharmacodynamics of a novel orally disintegrating tablet (ODT) formulation of delayed-release dexlansoprazole 30 mg was evaluated versus the dexlansoprazole 30 mg capsule in this phase I, open-label, multiple-dose, randomized, two-period crossover study. METHODS:...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076779/ https://www.ncbi.nlm.nih.gov/pubmed/27803731 http://dx.doi.org/10.1177/1756283X16670073 |